Viewing Study NCT03359304


Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2025-12-30 @ 11:58 PM
Study NCT ID: NCT03359304
Status: NOT_YET_RECRUITING
Last Update Posted: 2017-12-02
First Post: 2017-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Neurofibromatosis-associated Tumor Biobank
Sponsor: Ren tingting
Organization:

Study Overview

Official Title: Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction
Status: NOT_YET_RECRUITING
Status Verified Date: 2017-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research
Detailed Description: Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material.

Questionnaire information, including health history, growth and development, physical activity and family medical history information.

If patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in, the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: